Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-03-03 @ 6:44 PM
Study NCT ID:
NCT04148118
Status:
COMPLETED
Last Update Posted:
2022-05-18
First Post:
2019-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults
Sponsor:
BlueWillow Biologics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-28
First Submit QC Date:
None
Study First Post Date:
2019-11-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-12
Last Update Post Date:
2022-05-18
Last Update Post Date Type:
ACTUAL